Stockscreener 앱 받기
2.84
3.27%
0.09
시간 외 거래:
2.80
-0.04
-1.41%
Mdxhealth Sa 주식(MDXH)의 최신 뉴스
MDxHealth SA Flashes Buy Signal on Multi Timeframe ChartJuly 2025 Macro Moves & Real-Time Market Trend Scan - newsyoung.net
Earnings call transcript: MDxHealth Q2 2025 sees revenue growth, stock jumps - Investing.com Australia
MDxHealth SA reports results for the quarter ended June 30Earnings Summary - TradingView
How to integrate MDxHealth SA into portfolio analysis toolsTrade Exit Report & AI Powered Market Trend Analysis - Newser
MDxHealth SA stock trend forecastQuarterly Trade Review & Free Low Drawdown Momentum Trade Ideas - Newser
Using RSI to spot recovery in MDxHealth SABond Market & Weekly Return Optimization Alerts - Newser
MDxHealth (MDXH) Expected to Announce Quarterly Earnings on Wednesday - Defense World
What MACD and RSI say about MDxHealth SAJuly 2025 Drop Watch & Capital Efficient Trade Techniques - Newser
Automated trading signals detected on MDxHealth SAFree Daily Volume Spike Trading Signals - Newser
Why MDxHealth SA stock attracts strong analyst attentionMarket Activity Recap & Weekly Sector Rotation Insights - Newser
What makes MDxHealth SA stock price move sharplyMulti-Timeframe Confluence Picks - thegnnews.com
Will MDxHealth SA stock recover after recent dropPredictable Entry Strategy With Technical Backing - Newser
News impact scoring models applied to MDxHealth SADaily Market Movers Screener with Filters - Newser
MDxHealth SA stock prediction for this week3-Day Market Movement Forecast Analysis - Newser
MDxHealth SA Hits Oversold Level on RSI IndicatorWeekly Return Pick Forecast Reports Show Trend - beatles.ru
Earnings visualization tools for MDxHealth SAConsistent Gain Plan with AI Support - Newser
Is MDxHealth SA forming a bottoming baseStock Performance Summary Over One Year - Newser
Financial Analysis: MDxHealth (NASDAQ:MDXH) and Standard BioTools (NASDAQ:LAB) - Defense World
Order flow analysis tools used on MDxHealth SAReal Trader Watchlist with Entry Targets - Newser
Bio-Techne takes a hit on Exodx sale to Mdxhealth - BioWorld MedTech
MDxHealth SA (MDXH) Reports Q2 Loss, Tops Revenue Estimates - MSN
MDxHealth SA (MDXH) Q2 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ... - Yahoo Finance
MDxHealth ADR earnings missed by $0.03, revenue topped estimates - Investing.com South Africa
MDxHealth Announces Q2 Results and Strategic Acquisition of Exosome Diagnostics - TipRanks
Bio-Techne announces Exosome Diagnostics divestiture - MSN
Bio-techne to sell exosome diagnostics business to mdxhealth By Investing.com - Investing.com Australia
Bio-techne to sell exosome diagnostics business to mdxhealth - Investing.com
Bio-Techne Sells Prostate Cancer Test Business to Strengthen Core Operations: Strategic Shift Revealed - Stock Titan
Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne - The Manila Times
MDxHealth Hits Profitability Milestone and Expands Diagnostic Portfolio with Strategic $15M ExoDx Acquisition - Stock Titan
MACD Cross Could Confirm Trend in MDxHealth SATarget Return Focused Trade Insights Shared - metal.it
Is MDxHealth SA a growth stock or a value stockOutstanding capital growth - Jammu Links News
When is MDxHealth SA stock expected to show significant growthUnlock expert trading strategies for growth - Jammu Links News
What are the latest earnings results for MDxHealth SACapitalize on momentum-driven investment opportunities - Jammu Links News
Is MDxHealth SA stock overvalued or undervaluedUnlock exclusive stock market insights - Jammu Links News
Why is MDxHealth SA stock attracting strong analyst attentionMaximize returns with expert trading insights - Jammu Links News
How does MDxHealth SA compare to its industry peersExceptional stock performance - Jammu Links News
How many analysts rate MDxHealth SA as a “Buy”Unlock powerful market trend analysis - Jammu Links News
1.12%
0.47%
자본화:
|
볼륨(24시간):